If you need more lookups,
subscriptions start at $34 USD/month.
Joel Kaye Location
Israel
Joel Kaye Work
Chief Development Officer (CDO) @ (September 2024 - Present)
Senior Vice President Nonclinical Development @ (March 2022 - September 2024)
Vice President Research and Non-Clinical Development @ (December 2018 - March 2022)
Director, Pharmacology Project Leader @ (January 2012 - December 2015)
Head of Cancer Pharmacology and New Model Development @ (January 2011 - January 2012)
Team Leader - Pharmacology Department @ (October 2004 - January 2010)
Senior Manager @ (January 2004 - January 2009)
Group Leader @ (January 2004 - January 2004)
Postdoctoral Fellow @ (January 2001 - January 2003)
PHD Student @ (January 1996 - January 2000)
Joel Kaye Education
Harvard Medical School
(Immunology)
2001-2003
Weizmann Institute of Science
Doctor of Philosophy (Immunology)
1996-2000
The University of Western Australia
Bachelor of Science
1990-1994
Carmel School 1984-1988
Joel Kaye Skills
Lifesciences
Drug Discovery
Drug Development
Immunology
Pharmaceutical Industry
In Vivo
Oncology
In Vitro
Pharmacology
Animal Models
CRO
Joel Kaye Summary
Joel Kaye, based in Israel, is currently a Chief Development Officer (CDO) at 1E Therapeutics. Joel Kaye brings experience from previous roles at 1e Therapeutics, Ayala Pharmaceuticals and Teva Pharmaceuticals. Joel Kaye holds a 2001 - 2003 Harvard Medical School. With a robust skill set that includes Lifesciences, Drug Discovery, Drug Development, Immunology, Pharmaceutical Industry and more. Joel Kaye has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Joel Kaye?
Find contact details for 700 million professionals.